SLGL
Sol Gel Technologies Ltd
NASDAQ: SLGL · HEALTHCARE · BIOTECHNOLOGY
$74.04
+3.70% today
Updated 2026-04-30
Market cap
$230.14M
P/E ratio
—
P/S ratio
11.87x
EPS (TTM)
$-2.19
Dividend yield
—
52W range
$4 – $98
Volume
0.0M
Sol Gel Technologies Ltd (SLGL) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |